High-level expression of biologically active human follicle stimulating hormone in the Chinese hamster ovary cell line by a pair of tricistronic and monocistronic vectors

PLoS One. 2019 Jul 5;14(7):e0219434. doi: 10.1371/journal.pone.0219434. eCollection 2019.

Abstract

Recombinant human follicle stimulating hormone (FSH), produced in Chinese hamster ovary (CHO) cells, is widely used for treatment of fertility disorders and is subject to biosimilars development. Cell lines with high specific productivities may simplify the FSH production process. Here, we used our previously established expression system based on vector p1.1 to create new cell lines secreting heterodimeric FSH protein. To this end, we linked open reading frames of both FSH subunits by the wild-type internal ribosome entry site from the encephalomyocarditis virus (EMCV IRES). Intact and double-negative for the dihydrofolate reductase CHO cells were stably transfected by the FSH-coding plasmids. Stably transfected intact cells showed higher level of the FSH secretion and were utilized for subsequent methotrexate-driven transgene amplification, which doubled their productivity. The excess of the free α-subunit was corrected by transfecting the cells by the additional p1.1-based plasmid encoding the β-subunit of the FSH. Clonal cell lines obtained secreted mostly the heterodimeric FSH and possessed specific productivities up to 12.3±1.7 pg/cell/day. Candidate clonal cell line C-P1.3-FSH-G4 maintained a constant specific productivity for at least 2 months of culturing without the section pressure. The resulting FSH protein conformed to the international pharmaceutical quality criteria as evidenced by the receptor binding kinetics, distribution pattern of hormone isoforms and biological activity. In conclusion, our expression system offers a simple and cost-effective approach to production of FSH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cell Line
  • Cricetulus
  • Enzyme-Linked Immunosorbent Assay
  • Follicle Stimulating Hormone, Human / genetics*
  • Follicle Stimulating Hormone, Human / metabolism*
  • Gene Expression*
  • Gene Order
  • Genetic Vectors / genetics*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Plasmids / genetics
  • Polymerase Chain Reaction
  • Polysaccharides
  • Recombinant Proteins / genetics*
  • Recombinant Proteins / metabolism*
  • Sensitivity and Specificity

Substances

  • Follicle Stimulating Hormone, Human
  • Polysaccharides
  • Recombinant Proteins

Grants and funding

The project was supported by the grant 16-34-60242 of the Russian Foundation for Basic Research (Moscow, Russia; website https://www.rfbr.ru/rffi/eng) to NAO in a part of p1.1 derivative vectors comparison and investigation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project was supported by IVFarma LLC (Moscow, Russia, website http://ivfarma.ru), having a contract № 105/12 dated by October, 15th, 2012 with the Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences. Contract was devoted to the creation of the FSHproducing cell-line, purification and characterization of the secreted product. According to the terms of the contract, the funding was received by the Institute of Bioengineering and it was spent in part on materials and reagents and employee (SVK, YAK, NAO, IIV) salaries. The funder also provided direct support in the form of the research materials and reagents. IVFarma LLC also provided support in the form of salary for VAN (short-term service contract) and to MAP (this company is his permanent job). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding organizations do not object and do not limit in any form of publication of articles on the topic of this study and/or sharing of data and/or materials included to our manuscript and supporting materials.